From Medscape Oncology

European Hematology Association (EHA) 2023 Annual Meeting

June 08 - 11, 2023; Frankfurt, Germany and Virtual/Online

June 08 - 11, 2023 Frankfurt, Germany and Virtual/Online

Medscape Oncology© WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Perspectives

Popular News from Last Year’s EHA Annual Meeting

New CAR-T Therapy Elicits Strong Response in Multiple Myeloma In a small study, one infusion of the investigational CAR T-cell therapy led to a complete response in most patients with no CAR-T-related neurotoxicity.
Medscape Medical News, June 16, 2022
New Therapy May Offer 'Functional Cure' for Two Blood Disorders One infusion of an investigational gene editing therapy could eliminate red blood cell transfusions in beta-thalassemia and severe vaso-occlusive crises in sickle cell disease.
Medscape Medical News, June 14, 2022
Severe COVID-19 and Blood Cancer: Plasma Therapy May Help A new study found that among a subgroup of patients with hematologic/solid cancers and COVID-19, the time to symptom improvement was shorter and overall survival was better with plasma therapy.
Medscape Medical News, Jun 10, 2022

Previous Coverage